Insights

Rapid Turnaround Biopsy Diagnostics emphasizes rapid turnaround and outpatient pathology, presenting a selling point to urgent care centers, dermatology clinics, surgical centers, and community hospitals that require fast biopsy results without sending specimens to distant reference labs.

Subspecialty Access As a regional outpatient lab with focus on skin, prostate, GI, breast, gynecologic sites and bladder, BXDX can win referrals from specialists needing subspecialty interpretation; propose targeted outreach to dermatology, urology, GI clinics in Southeast, AZ, NY to capture high-volume biopsies.

Geographic Expansion Current service footprint includes SE US, AZ, NY; opportunities to expand via contract arrangements with hospital groups and clinics in these markets, offering outsourced pathology coverage, on-site lab partnerships, or remote sign-out via telepathology.

Digital Enablement Investing in digital pathology, LIS/EHR integration, and telepathology can appeal to larger networks and enable scalable service across multi-site health systems, reducing turnaround times and improving specimen tracking.

Regional Differentiation Position BXDX as a high-service, fast-turnaround regional alternative to large national labs for outpatient specimens, offering flexible SLAs, responsive account management, and localized service to differentiate from bigger players.

Biopsy Diagnostics Tech Stack

Media & News

Biopsy Diagnostics's Email Address Formats

Biopsy Diagnostics uses at least 1 format(s):
Biopsy Diagnostics Email FormatsExamplePercentage
First.Last@bx-dx.comJohn.Doe@bx-dx.com
60%
First@bx-dx.comJohn@bx-dx.com
40%

Frequently Asked Questions

What is Biopsy Diagnostics's official website and social media links?

Minus sign iconPlus sign icon
Biopsy Diagnostics's official website is bx-dx.com and has social profiles on LinkedIn.

What is Biopsy Diagnostics's NAICS code?

Minus sign iconPlus sign icon
Biopsy Diagnostics's NAICS code is 62 - Health Care and Social Assistance.

How many employees does Biopsy Diagnostics have currently?

Minus sign iconPlus sign icon
As of July 2026, Biopsy Diagnostics has approximately 25 employees across 1 continents, including North America. Key team members include Histology Supervisor: R. L.Office Administrator: C. G.Medical Biller: V. J.. Explore Biopsy Diagnostics's employee directory with LeadIQ.

What industry does Biopsy Diagnostics belong to?

Minus sign iconPlus sign icon
Biopsy Diagnostics operates in the Hospitals and Health Care industry.

What is Biopsy Diagnostics's email format?

Minus sign iconPlus sign icon
Biopsy Diagnostics's email format typically follows the pattern of First.Last@bx-dx.com. Find more Biopsy Diagnostics email formats with LeadIQ.
Biopsy Diagnostics logo

Biopsy Diagnostics

Hospitals and Health CareUnited States11-50 Employees

Biopsy Diagnostics is a regional pathology laboratory based in Okatie, South Carolina, serving outpatient specimens from multiple bodily sites, with a focus on skin, prostate, GI tract, breast, gynecologic sites, and bladder. The organization emphasizes high-quality, rapid turnaround diagnostic pathology services for patients and practitioners across the southeastern United States, Arizona, and New York, positioning itself within the hospitals and health care industry as a specialized outpatient diagnostic provider. Its operations are oriented toward delivering timely and reliable anatomic pathology assessments for outpatient specimens, supporting clinicians in making informed treatment decisions. The company operates with a relatively small team and locations its services to meet the needs of outpatient and regional healthcare settings. The information notes the company’s presence in the United States and identifies its core service scope and geographic reach as the basis for its market positioning.

Section iconCompany Overview

Website
bx-dx.com
NAICS Code
62 - Health Care and Social Assistance
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $1M$10M

    Biopsy Diagnostics's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Biopsy Diagnostics's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.